Effect of Liver Cirrhosis on the Pharmacokinetics, Metabolism, and Tolerability of Daridorexant, A Novel Dual Orexin Receptor Antagonist.
Benjamin BergerJasper DingemanseGiancarlo SabattiniStéphane DelahayeUrs DuthalerClemens MuehlanStephan KrähenbühlPublished in: Clinical pharmacokinetics (2021)
ClinicalTrials.gov ID: NCT03713242.